Regulation of Costimulatory Signal in Maternal–Fetal Immune Tolerance

L. P. Jin,D. X. Fan,D. J. Li
DOI: https://doi.org/10.1111/j.1600-0897.2010.00982.x
2011-01-01
American Journal of Reproductive Immunology
Abstract:Citation Jin L‐P, Fan D‐X, Li D‐J. Regulation of costimulatory signal in maternal‐fetal immune tolerance. Am J Reprod Immunol 2011; 66: 76–83A pregnancy is associated with modifications in the immune status of the mother, but the mechanisms are not well understood. Several observations have indicated that CD28/CTLA‐4 and B7‐1/B7‐2 are involved in the maternal–fetal immune regulation. This review aims to recapitulate our current knowledge concerning the role of CD28/CTLA‐4 and B7‐1/B7‐2 in maternal–fetal immune regulation. Several studies suggest that up‐regulation of B7‐2 and/or CD28 and/or down‐regulation of CTLA‐4 are correlated with the occurrence of pregnancy loss. Therefore, an accurate expression of costimulatory molecules at the maternal–fetal interface may ensure that the decidual cells do not elicit a ‘danger’ signal to the maternal immune system, perhaps instead contributing to the establishment of immune tolerance in vivo. It is showed that costimulation blockade with anti‐B7 mAbs results in altered allogeneic T‐cell response and overcomes increased maternal rejection to the fetus, which improves fetus growth in the abortion‐prone system. These findings suggest that the anti‐B7‐treated T cells not only function as potent suppresser cells but also exert immunoregulatory effect on the maternal T cells. This procedure might be potentially useful to immunotherapy for human recurrent spontaneous abortion.
What problem does this paper attempt to address?